Cabaletta Bio, Inc.
CABA
$1.56
-$0.03-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.55% | -10.30% | -6.39% | -10.97% | -10.20% |
| Total Depreciation and Amortization | -3.51% | 3.63% | 10.38% | -0.47% | 8.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.01% | 25.82% | -12.34% | 8.82% | 33.82% |
| Change in Net Operating Assets | 233.41% | -206.02% | -0.83% | 9,448.39% | 99.25% |
| Cash from Operations | 1.22% | -33.22% | -13.77% | 2.24% | 13.34% |
| Capital Expenditure | 79.49% | -108.78% | -48.62% | 67.14% | 5.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00% | -48.98% | -- |
| Cash from Investing | -6,167.01% | -106.47% | -1.00% | -48.39% | 3,022.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -443.84% | 38.46% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 7,321.13% | -81.27% | -94.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17,015.40% | -112.63% | 6,057.75% | -81.27% | -94.47% |
| Foreign Exchange rate Adjustments | 342.86% | 135.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.89% | -383.48% | 16.98% | -341.11% | 118.50% |